La mitad de los participantes del grupo de semaglutida pudieron perder al menos el 15% de su peso corporal, y casi un tercio pudieron perder el 20%
Cardiologists involved in obesity research have raised particular concern about sympathomimetic-GLP-1 combinations in patients with hypertension, arrhythmia history, or coronary artery disease
Semaglutide may cause side effects, including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, especially when starting treatment
With annual costs exceeding $15,000 for medications like Wegovy, many patients find themselves paying premium prices while waiting months to see significant changes
However, some prefer the simplicity of fewer doses per week
REBOUND - $190 "Myers Cocktail", the rebound recovery after an evening out